Data, surveillance and research on opioids and other substances
Links to evidence guiding the Government of Canada's response to the toxic drug crisis.
On this page
- Get the latest data
- Statement from the Council of Chief Medical Officers of Health on the crisis
- Federal actions on the overdose crisis
- Reports, studies and surveys
Get the latest data
Access the most recent data on opioid- and stimulant-related harms in Canada
(Last updated: June 2026)
- Apparent opioid and stimulant toxicity deaths
- Opioid- and stimulant-related poisoning hospitalizations
- Opioid- and stimulant-related poisoning emergency department visits
- Emergency Medical Services responses to suspected opioid-related overdoses
Statement from the Council of Chief Medical Officers of Health
Members of the Council of Chief Medical Officers of Health share their perspectives on the latest data release, the toxic drug crisis and actions being taken to mitigate further substance-related harms in Canada.
Read the statement (Last updated: June 2026)
Federal actions on the overdose crisis
Read about the Government of Canada's actions to address the overdose crisis and help save lives, including:
- government funding for projects
- prevention and education efforts
- evidence used for decision-making
- substance use services and supports
- substance controls
Read more about Federal actions on the overdose crisis (Last updated: June 2026)
Reports, studies and surveys
Read the Government of Canada's studies and published reports on the toxic drug crisis at the national level.
Public Health Agency of Canada
- Benzodiazepines in apparent drug toxicity deaths in Canada, 2018 to 2024
- Fentanyl analogues in apparent opioid toxicity deaths in Canada, 2018 to 2024
- Potential factors to explain the decline in opioid-related deaths in 2024
- Nitazenes in apparent opioid toxicity deaths in Canada, 2020 to 2024
- Xylazine in apparent drug toxicity deaths in Canada, 2019 to 2024
- Multi-Drug Involvement in Apparent Opioid and Stimulant Toxicity Deaths in Canada from 2018 to 2023
- Modelling opioid-related deaths during the overdose crisis (Last updated: December 2024)
Other reports, studies and surveys
- Benzodiazepines in apparent drug toxicity deaths in Canada, 2018 to 2023: Infographic
- Multi-drug combinations in opioid- or stimulant-related toxicity deaths in Canada: Infographic
- Multi-Drug Combinations in national apparent opioid and stimulant toxicity deaths
- Substance-related acute toxicity deaths in Canada from 2016 to 2017: A review of coroner and medical examiner files
- Characteristics of patients with repeat emergency department visits for opioid-related harms in Alberta, Ontario and the Yukon
- Substance-related poisoning hospitalizations among people who are pregnant in Canada
- Characteristics of patients with repeat hospitalizations for substance-related harms in Canada
- Area-level characteristics of substance-related acute toxicity deaths: a descriptive analysis of coroner and medical examiner data
- Canada-U.S. joint white paper: Substance use and harms during the covid-19 pandemic and approaches to federal surveillance and response
- Homelessness and substance-related acute toxicity deaths: a descriptive analysis of coroner and medical examiner data
- Opioid pain relief medication use and mood disorders in Canada: a descriptive analysis of Canadian Community Health Survey data
- Neonatal abstinence syndrome in Canada: a descriptive analysis of hospitalization data
- Substance-related poisonings and homelessness in Canada: a descriptive analysis of hospitalization data
- Opioid-related poisoning and anoxic brain injury in Canada: a descriptive analysis of hospitalization data
- Opioid-related harms and mental disorders in Canada: a descriptive analysis of hospitalization data
- Understanding a broader range of opioid-related hospitalizations in Canada
- Integrating Emergency Medical Service, hospitalization, and death data
- National qualitative study highlights: Insights from coroners and medical examiners
- Impact of the opioid overdose epidemic on life expectancy at birth
Health Canada
- Canadian Drugs and Substances Strategy: Evidence
- Latest data on new and emerging substances from the Canadian Drug and Substance Watch
- Canada's overdose crisis and the toxic illegal drug supply
- Latest data on supervised consumptions sites in Canada
- Drug Analysis Service reports